Nurse practitioner prescriptive authority varies by state across three models: full practice, reduced practice, and restricted practice. In full practice states, you can evaluate patients, diagnose, and prescribe — including controlled substances — without a physician agreement. In reduced and restricted states, you need a written collaborative or supervisory arrangement with a physician, and that agreement defines what you can prescribe. All 50 states grant some level of prescriptive authority, but the schedules you can reach and the paperwork you must keep differ depending on where you practice.
Full Practice States
Under the full practice model, state law authorizes you to evaluate patients, make diagnoses, and prescribe medications — including controlled substances — without a collaborative agreement or physician oversight. Your state board of nursing governs your practice directly, and you don’t need a physician’s signature to write a prescription or manage a patient panel.
More than half of U.S. states plus the District of Columbia now operate under this model. The number has grown steadily over the past decade, with states like New York, Massachusetts, and Kansas joining earlier adopters such as Oregon and Montana. Practitioners in these states carry full professional responsibility for their clinical decisions and can refer patients to specialists independently.
The practical effect is significant. Full practice authority eliminates the administrative overhead of maintaining a collaborative agreement, removes a barrier in regions where collaborating physicians are scarce, and lets you open an independent practice. State boards still enforce licensing requirements, continuing education mandates, and discipline.
Reduced Practice States
In reduced practice states, you must maintain a collaborative agreement with a physician for the duration of your career. This written agreement defines the scope of your prescriptive authority and establishes the terms of the professional relationship. The specifics vary. Some states require the collaborating physician to co-sign certain prescription types; others simply require that an agreement exists on file and can be produced during an audit.
The agreement is not a formality. Letting it lapse, prescribing outside its scope, or failing to produce records on request can cost you prescriptive privileges or trigger board discipline.
Restricted Practice States
Restricted practice states go further by requiring active supervision or delegation from a physician. Your prescribing authority in these states is treated as a delegated act rather than an independent professional function. The physician must typically review a portion of your patient charts on a regular schedule, and your prescriptive scope is defined by the supervisory agreement rather than by your license alone.
Supervision Ratios
States that require collaboration or supervision typically cap how many nurse practitioners a single physician can oversee. These limits range from roughly three to six full-time-equivalent practitioners per physician, depending on the state. Some states measure the cap in total weekly hours instead of headcount. Hospital-employed practitioners are often exempt. Before signing an agreement, confirm your collaborating physician has capacity under the applicable ratio.
What You Can Prescribe in Each State
Federal law divides controlled substances into five schedules based on abuse potential and accepted medical use.1Drug Enforcement Administration. Controlled Substance Schedules Schedule II includes opioids like hydrocodone, oxycodone, and fentanyl, plus stimulants like amphetamine and methylphenidate. Schedule III covers buprenorphine, low-dose codeine combinations, ketamine, and anabolic steroids. Schedule IV covers benzodiazepines such as alprazolam, diazepam, and lorazepam. Schedule V is primarily cough preparations with limited codeine content.
Most states authorize nurse practitioners to prescribe across Schedules II through V. A handful limit Schedule II access, a few restrict nurse practitioners to Schedules III through V entirely, and some allow only certain Schedule II medications like hydrocodone combinations. The schedules you can prescribe depend on your state’s practice act and any collaborative agreement in place.
Your federal registration doesn’t override state limits. The Attorney General registers practitioners — including nurse practitioners — to prescribe controlled substances in Schedules II through V, but only to the extent they are authorized under state law.2Office of the Law Revision Counsel. 21 USC 823 – Registration Requirements If your state caps you at Schedules III through V, your DEA number is capped there too.
Federal Registration You Need in Every State
The state model determines who oversees your prescribing. It doesn’t change the federal credentials you need before you write a single prescription.
National Provider Identifier
The NPI is a 10-digit identification number assigned to every healthcare provider in the United States. You apply through the National Plan and Provider Enumeration System (NPPES), maintained by the Centers for Medicare and Medicaid Services.3Centers for Medicare & Medicaid Services. National Provider Identifier Standard (NPI) The application asks for your state nursing license number. Providing a Social Security Number is technically optional, but CMS warns that skipping it can delay processing; applicants who don’t provide one must submit two alternate forms of identification.4Centers for Medicare & Medicaid Services. National Provider Identifier NPI Application/Update Form Once assigned, your NPI stays with you for your entire career regardless of where you practice.
DEA Registration
To prescribe controlled substances, you must register with the Drug Enforcement Administration using DEA Form 224.5Drug Enforcement Administration. Registration The application requires the business address where you’ll prescribe and your state license number confirming you’re authorized to handle controlled substances. The registration fee is $888 for a three-year cycle. The DEA no longer mails paper renewal notices; electronic reminders arrive at 60, 45, 30, 15, and 5 days before expiration, and all renewals are submitted online.
One point regularly misses prescribers: if your registration expires, you cannot prescribe controlled substances during the one-month reinstatement window. There is no federal grace coverage. The moment the registration lapses, you stop prescribing until it is reinstated.5Drug Enforcement Administration. Registration
MATE Act Training
Since June 2023, every practitioner applying for a new DEA registration or renewing an existing one must complete a one-time, eight-hour training course on treating patients with opioid and other substance use disorders. The requirement comes from the Medication Access and Training Expansion (MATE) Act.6Drug Enforcement Administration. Opioid Use Disorder – MATE Act Q&A
You satisfy it with eight hours of accredited continuing education from organizations like ASAM, AANP, ANCC, or the AMA. If you graduated from an accredited advanced practice nursing program within five years of June 27, 2023, and your curriculum included at least eight hours on substance use disorders, you already qualify. You attest on the DEA application by checking a box. No certificates are submitted, but keep your documentation on file.6Drug Enforcement Administration. Opioid Use Disorder – MATE Act Q&A
Medicare Ordering and Certifying
If any of your patients are Medicare beneficiaries, you need to be enrolled with CMS to order or certify items and services. To qualify, you must have an individual NPI (organizational NPIs don’t count) and be enrolled in Medicare in either “approved” or “opt-out” status. Nurse practitioners are listed as an eligible specialty type for ordering and certifying.7Centers for Medicare & Medicaid Services. Ordering & Certifying If you already bill Medicare as a Part B provider, you’re automatically authorized. If you don’t bill directly, you can still order and certify by enrolling solely in that capacity or by opting out. Skipping this step is a quiet compliance gap: orders and prescriptions get denied without clear explanation until someone traces it back to enrollment status.
Ongoing Compliance That Applies in Every State
Electronic Prescribing for Controlled Substances
Electronic prescribing for controlled substances (EPCS) has moved from optional to effectively required. To e-prescribe controlled substances, your software must meet DEA technical standards, including third-party certification, two-factor authentication, and FIPS-validated cryptographic signing. The application must maintain an audit trail of every action on a controlled substance prescription and retain those records for at least two years.8eCFR. 21 CFR Part 1311 – Requirements for Electronic Orders and Prescriptions
For the 2026 measurement year, CMS requires prescribers to electronically prescribe at least 70% of their Medicare Part D controlled substance prescriptions (Schedules II through V). Prescribers who write 100 or fewer qualifying controlled substance prescriptions in the year are automatically exempt. Prescriptions for patients in long-term care facilities are excluded from compliance calculations until 2028.9Centers for Medicare & Medicaid Services. MY 2026 CMS EPCS Program Requirement at a Glance A growing number of states have enacted their own EPCS mandates covering all payers, so paper prescriptions for controlled substances are becoming harder to use regardless of your patient population.
Prescription Drug Monitoring Programs
Prescription Drug Monitoring Programs (PDMPs) are state-run electronic databases that track controlled substance prescriptions filled within the state. No single federal law requires individual practitioners to register with or query a PDMP; the federal statute on this topic is a grant program encouraging states to build and maintain these systems.10Office of the Law Revision Counsel. 42 USC 280g-3 – Prescription Drug Monitoring Program The actual obligations come from state law, and most states now require prescribers to check the PDMP before writing certain controlled substance prescriptions.
The CDC recommends querying the PDMP before initiating opioid therapy and every three months (or more often) during ongoing opioid treatment.11Centers for Disease Control and Prevention. Prescription Drug Monitoring Programs (PDMPs) PDMP data increasingly crosses state lines. Two interstate hubs — RxCheck and PMP InterConnect — let states query each other’s databases. States receiving federal PDMP funding from the Bureau of Justice Assistance or the CDC are required to maintain a connection to the RxCheck hub.12RxCheck. Connecting to RxCheck Hub Even if your state only mandates a check before opioid prescriptions, a query can surface fills across multiple states.
Telehealth Prescribing
Since the COVID-19 public health emergency, practitioners have been able to prescribe controlled substances by telehealth without first conducting an in-person examination. The flexibility has been extended repeatedly. The most recent extension runs through December 31, 2026, giving the DEA and HHS more time to finalize permanent telehealth prescribing regulations, including a proposed Special Registration for Telemedicine.13U.S. Department of Health and Human Services. HHS & DEA Extend Telemedicine Flexibilities for Prescribing These flexibilities do not change the underlying rules: prescriptions must still be issued for a legitimate medical purpose, by a licensed practitioner, in compliance with federal and state law.
Penalties for Prescribing Outside Your Authority
Consequences come at both the administrative and criminal level, and regulators do not distinguish between intentional diversion and careless record-keeping when it comes to opening an enforcement action.
Administrative Sanctions
The DEA can suspend or revoke your registration if you falsify your application, lose your state license, get convicted of a controlled substance felony, or commit acts the agency considers inconsistent with the public interest. Before revoking, the DEA issues an order to show cause, giving you a chance to respond. When the agency believes there is an imminent danger to public health or safety, it can suspend immediately, before any hearing.14Drug Enforcement Administration. Practitioner’s Manual Losing DEA registration ends your ability to prescribe controlled substances nationwide, regardless of what your state license says.
Criminal Penalties
Prescribing controlled substances outside the usual course of professional practice, or knowingly filling a prescription not issued for a legitimate medical purpose, triggers the same federal penalties that apply to illegal drug distribution. The consequences scale by schedule:15Office of the Law Revision Counsel. 21 USC 841 – Prohibited Acts A
- Schedule I or II: up to 20 years in prison and fines up to $1,000,000. If a patient dies or suffers serious bodily injury, the minimum rises to 20 years.
- Schedule III: up to 10 years in prison and fines up to $500,000. Up to 15 years if death or serious injury results.
- Schedule IV: up to 5 years in prison and fines up to $250,000.
- Schedule V: up to 1 year in prison and fines up to $100,000.
Repeat offenders face substantially higher mandatory minimums, and sentences for the most serious offenses are not eligible for parole or probation.15Office of the Law Revision Counsel. 21 USC 841 – Prohibited Acts A These penalties were designed for drug traffickers, but they apply to practitioners. Federal prosecutors have increasingly targeted practitioners whose controlled substance prescribing falls outside recognized clinical standards.